These results are expected considering that other investigators have demonstrated anti-proliferative effects of celecoxib to extend beyond Cox-2 inhibition in colon cancer cell lines [48], hematopoietic and epithelial cell lines [49] and prostate cancer xenografts [50]. This evidence concerns the gene PTGS2 and Familial prostate cancer.